Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Technologies Secures $15M Senior Credit Facility

NEW YORK (GenomeWeb News) – NanoString Technologies has received $15 million in debt financing from Oxford Finance and Silicon Valley Bank.

The financing includes a $13 million senior secured term loan and a $2 million revolving line of credit and will be used to fund NanoString's growth and for working capital.

Based in Seattle, NanoString is developing a breast cancer assay based on expression of the PAM50 gene signature. It also makes the nCounter Analysis System, a fully automated digital gene expression tool that can multiplex hundreds of genes per sample and detect and count single molecules.

"This facility further strengthens NanoString's balance sheet, allowing us to continue growing our core life sciences business while aggressively pursuing the diagnostics opportunity," Wayne Burns, CFO of NanoString, said in a statement.

NanoString raised $20 million in a Series D round in November.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.